|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0700 USD | -53.33% |
|
-.--% | - |
| 06-08 | Ixico plc Announces Appointments on Scientific Advisory Board | CI |
| 06-08 | Ixico Has Enters into A Research Collaboration with the Paris Brain Institute | CI |
Company Valuation: IXICO plc
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 38.52 | 16.13 | 9.187 | 4.473 | 12.28 | 18.43 | - |
| Change | - | -58.13% | -43.05% | -51.32% | 174.54% | 50.06% | - |
| Enterprise Value (EV) 1 | 32.43 | 10.36 | 5.156 | 2.686 | 8.742 | 8.825 | 12.73 |
| Change | - | -68.05% | -50.24% | -47.91% | 225.51% | 0.95% | 44.19% |
| P/E | 25.6x | 16.5x | -7.79x | -2.23x | -7.16x | -5.28x | -6.5x |
| PBR | - | - | - | - | 1.01x | 0.97x | 1.14x |
| PEG | - | -0.5x | 0x | -0x | 0.1x | 0.4x | 0.3x |
| Capitalization / Revenue | 4.19x | 1.87x | 1.38x | 0.78x | 1.88x | 2.46x | 2.05x |
| EV / Revenue | 3.53x | 1.2x | 0.77x | 0.47x | 1.34x | 1.18x | 1.41x |
| EV / EBITDA | 19.1x | 6.91x | -6.44x | -1.58x | -6.49x | -4.2x | -5.3x |
| EV / EBIT | 27.5x | 11.4x | -3.59x | -1.25x | -3.42x | -3.53x | -4.39x |
| EV / FCF | - | - | -3.1x | -1.22x | -4.22x | -2.67x | -3.26x |
| FCF Yield | - | - | -32.2% | -82% | -23.7% | -37.4% | -30.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | 0.0312 | 0.0203 | -0.0244 | -0.0414 | -0.0185 | -0.016 | -0.013 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 9.19 | 8.643 | 6.665 | 5.766 | 6.534 | 7.5 | 9 |
| EBITDA 1 | 1.7 | 1.5 | -0.8 | -1.7 | -1.346 | -2.1 | -2.4 |
| EBIT 1 | 1.181 | 0.908 | -1.437 | -2.154 | -2.554 | -2.5 | -2.9 |
| Net income 1 | 1.575 | 1.035 | -1.178 | -2.001 | -1.651 | -2.4 | -2.8 |
| Net Debt 1 | -6.087 | -5.769 | -4.031 | -1.787 | -3.537 | -9.6 | -5.7 |
| Reference price 2 | 0.8000 | 0.3350 | 0.1900 | 0.0925 | 0.1325 | 0.0845 | 0.0845 |
| Nbr of stocks (in thousands) | 48,151 | 48,151 | 48,351 | 48,351 | 92,669 | 218,048 | - |
| Announcement Date | 12/7/21 A | 12/7/22 A | 12/5/23 A | 12/4/24 A | 12/9/25 A | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.21x | 5.68x | 17.59x | 1.02% | 46.2B | ||
| -22.9x | 343.72x | -21.86x | -.--% | 38.71B | ||
| 23.26x | 2.64x | 11.39x | -.--% | 31.9B | ||
| 41.76x | 4.18x | 26.75x | -.--% | 31.12B | ||
| 27.93x | 7.24x | 18.62x | 0.45% | 23.77B | ||
| 30.92x | 5x | 22.8x | -.--% | 15.05B | ||
| 23.95x | 2.04x | 8.96x | 1.12% | 13.74B | ||
| -22.52x | 14.77x | -22.09x | -.--% | 13.42B | ||
| Average | 16.83x | 48.16x | 7.77x | 0.32% | 26.74B | |
| Weighted average by Cap. | 17.76x | 66.64x | 8.30x | 0.34% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IXI Stock
- PHYOF Stock
- Valuation IXICO plc
Select your edition
All financial news and data tailored to specific country editions
















